Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 713728, 9 pages
http://dx.doi.org/10.1155/2015/713728
Review Article

Clinical Characteristics of Concomitant Systemic Lupus Erythematosus and Primary Biliary Cirrhosis: A Literature Review

Department of Physiology, School of Medicine, Tokai University, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan

Received 18 September 2014; Accepted 17 January 2015

Academic Editor: Michael H. Kershaw

Copyright © 2015 Toru Shizuma. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Bouman, M. Jan Heineman, and M. M. Faas, “Sex hormones and the immune response in humans,” Human Reproduction Update, vol. 11, no. 4, pp. 411–423, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Wang, F.-C. Zhang, H. Chen et al., “Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study,” World Journal of Gastroenterology, vol. 19, no. 31, pp. 5131–5137, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. D. C. T. Oh, T. M. Ng, J. Ho, and K. P. Leong, “Systemic lupus erythematosus with concurrent protein-losing enteropathy and primary sclerosing cholangitis: a unique association,” Lupus, vol. 15, no. 2, pp. 102–104, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. O. P. Rekvig and J. Van der Vlag, “The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved,” Seminars in Immunopathology, vol. 36, no. 3, pp. 301–311, 2014. View at Publisher · View at Google Scholar
  5. J. de Azevêdo Silva, C. Addobbati, P. Sandrin-Garcia, and S. Crovella, “Systemic lupus erythematosus: old and new susceptibility genes versus clinical manifestations,” Current Genomics, vol. 15, no. 1, pp. 52–65, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. H. P. Stevens, L. S. Ostlere, and M. H. A. Rustin, “Systemic lupus erythematosus in association with ulcerative colitis: related autoimmune diseases,” British Journal of Dermatology, vol. 130, no. 3, pp. 385–389, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. D. A. Medeiros and D. A. Isenberg, “Systemic lupus erythematosus and ulcerative colitis,” Lupus, vol. 18, no. 8, pp. 762–763, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Efe, T. Purnak, E. Ozaslan, and Z. Ozbalkan, “The importance of autoimmune hepatitis and primary biliary cirrhosis in patients with systemic lupus erythematosus,” Lupus, vol. 20, no. 1, p. 112, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Ishiguro, T. Kimura, T. Nikami et al., “A case of primary biliary cirrhosis associated with hepatocellular carcinoma and systemic lupus erythematodes,” Kanzo, vol. 52, no. 10, pp. 679–686, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Harada and Y. Nakanuma, “Prevalence and risk factors of hepatocellular carcinoma in Japanese patients with primary biliary cirrhosis,” Hepatology Research, vol. 44, no. 2, pp. 133–140, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Hohenester, R. P. J. Oude-Elferink, and U. Beuers, “Primary biliary cirrhosis,” Seminars in Immunopathology, vol. 31, no. 3, pp. 283–307, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Momah and K. D. Lindor, “Primary biliary cirrhosis in adults,” Expert Review of Gastroenterology and Hepatology, vol. 8, no. 4, pp. 427–433, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. C. L. Bowlus and M. E. Gershwin, “The diagnosis of primary biliary cirrhosis,” Autoimmunity Reviews, vol. 13, no. 4-5, pp. 441–444, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. E. Gershwin, C. Selmi, H. J. Worman et al., “Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients,” Hepatology, vol. 42, no. 5, pp. 1194–1202, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Selmi, C. L. Bowlus, M. E. Gershwin, and R. L. Coppel, “Primary biliary cirrhosis,” The Lancet, vol. 377, no. 9777, pp. 1600–1609, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Granito, P. Muratori, L. Muratori et al., “Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis,” Alimentary Pharmacology and Therapeutics, vol. 26, no. 6, pp. 831–838, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. G. D. Iliffe, S. Naidoo, and T. Hunter, “Primary biliary cirrhosis associated with features of systemic lupus erythematosus,” Digestive Diseases and Sciences, vol. 27, no. 3, pp. 274–278, 1982. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Hall, P. H. Axelsen, D. E. Larson, and T. W. Bunch, “Systemic lupus erythematosus developing in patients with primary biliary cirrhosis,” Annals of Internal Medicine, vol. 100, no. 3, pp. 388–389, 1984. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Y. Chan, S. D. Lee, Y. S. Huang et al., “Primary biliary cirrhosis in Taiwan,” Journal of Gastroenterology and Hepatology, vol. 5, no. 5, pp. 560–565, 1990. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Clark and K. Sack, “Deforming arthropathy complicating primary biliary cirrhosis,” Journal of Rheumatology, vol. 18, no. 4, pp. 619–621, 1991. View at Google Scholar · View at Scopus
  21. F. Nachbar, H. C. Korting, R. M. Hoffmann, M. Kollmann, and M. Meurer, “Unusual coexistence of systemic lupus erythematosus and primary biliary cirrhosis,” Dermatology, vol. 188, no. 4, pp. 313–317, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Schifter and U. H. Lewinski, “Primary biliary cirrhosis and systemic lupus erythematosus. A rare association,” Clinical and Experimental Rheumatology, vol. 15, no. 3, pp. 313–314, 1997. View at Google Scholar · View at Scopus
  23. F. Michel, E. Toussirot, and D. Wendling, “Primary biliary cirrhosis and systemic lupus erythematosus. A new case report,” Revue du Rhumatisme (English Edition), vol. 65, no. 7–9, pp. 504–507, 1998. View at Google Scholar · View at Scopus
  24. S. Islam, J. W. Riordan, and J. A. McDonald, “Case report: a rare association of primary biliary cirrhosis and systemic lupus erythematosus and review of the literature,” Journal of Gastroenterology and Hepatology, vol. 14, no. 5, pp. 431–435, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Shizuma and H. Kuroda, “A case of primary biliary cirrhosis which developed eight years after diagnosis of systemic lupus erythematosus,” Internal Medicine, vol. 50, no. 4, pp. 321–324, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Hammami, N. Chaabane, H. Mahmoudi, F. Bdioui, and H. Saffar, “Late-onset systemic lupus erythematosus-associated primary biliary cirrhosis,” International Archives of Medicine, vol. 6, no. 1, article 3, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Seki, K. Tanaka, M. Fujisawa et al., “A patient with asymptomatic primary biliary cirrhosis in association with Sjögren syndrome developing features of systemic lupus erythematosus,” Japanese Journal of Gastroenterology, vol. 83, no. 11, pp. 2445–2449, 1986. View at Google Scholar · View at Scopus
  28. T. Takeuchi, M. Kimura, N. Nishioka et al., “Hepatic involvement in systemic lupus erythematosus—a case of systemic lupus erythematosus associated with primary biliary cirrhosis,” Clinical Rheumatology and Related Research, vol. 1, no. 1, pp. 121–129, 1988. View at Google Scholar
  29. E. Yokota, H. Fukuda, K. Yamaoka et al., “A case of systemic lupus erythematosus developing in patient with primary biliary cirrhosis,” Riumachika, vol. 13, no. 5, pp. 428–436, 1995. View at Google Scholar
  30. K. Yamamoto, K. Inoue, and M. Kanai, “A case of systemic lupus erythematosus and primary biliary cirrhosis,” Japanese Journal of Clinical Dermatology, vol. 57, no. 4, pp. 386–389, 2003. View at Google Scholar
  31. S. I. Sato, K. Abe, K. Sawara et al., “Familial occurrence of primary biliary cirrhosis in a father and daughter,” Acta Hepatologica Japonica, vol. 44, no. 12, pp. 656–662, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Saito, A. Takahashi, K. Abe et al., “Two cases of primary biliary cirrhosis associated with systemic lupus erythematosus,” Kanzo, vol. 52, no. 3, pp. 169–175, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Carbone, A. Lleo, R. N. Sandford, and P. Invernizzi, “Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosis,” European Journal of Immunology, vol. 44, no. 4, pp. 945–954, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Raszeja-Wyszomirska and T. Miazgowski, “Osteoporosis in primary biliary cirrhosis of the liver,” Przeglad Gastroenterologiczny, vol. 9, no. 2, pp. 82–87, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. O. G. Tunccan, A. Tufan, G. Telli et al., “Visceral leishmaniasis mimicking autoimmune hepatitis, primary biliary cirrhosis, and systemic lupus erythematosus overlap,” Korean Journal of Parasitology, vol. 50, no. 2, pp. 133–136, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Yu, M. E. Gershwin, and C. Chang, “Diagnostic criteria for systemic lupus erythematosus: a critical review,” Journal of Autoimmunity, vol. 48-49, pp. 10–13, 2014. View at Publisher · View at Google Scholar
  37. C. Efe, T. Purnak, E. Ozaslan et al., “Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases,” Scandinavian Journal of Gastroenterology, vol. 46, no. 6, pp. 732–737, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M. De Santis, C. Crotti, and C. Selmi, “Liver abnormalities in connective tissue diseases,” Best Practice and Research: Clinical Gastroenterology, vol. 27, no. 4, pp. 543–551, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. B. A. Runyon, D. R. LaBrecque, and S. Anuras, “The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature,” The American Journal of Medicine, vol. 69, no. 2, pp. 187–194, 1980. View at Publisher · View at Google Scholar · View at Scopus
  40. S. N. Heyman, G. Spectre, S. Aamar, D. Rubinger, O. Pappo, and Z. Ackerman, “Autoimmune cholangiopathy associated with systemic lupus erythematosus,” Liver, vol. 22, no. 2, pp. 102–106, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. K. S. Irving, D. Sen, H. Tahir, C. Pilkington, and D. A. Isenberg, “A comparison of autoimmune liver disease in juvenile and adult populations with systemic lupus erythematosus—a retrospective review of cases,” Rheumatology, vol. 46, no. 7, pp. 1171–1173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. V. R. Chowdhary, C. S. Crowson, J. J. Poterucha, and K. G. Moder, “Liver involvement in systemic lupus erythematosus: case review of 40 patients,” Journal of Rheumatology, vol. 35, no. 11, pp. 2159–2164, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Her, Y. Lee, E. Jung, T. Kim, and D. Kim, “Liver enzyme abnormalities in systemic lupus erythematosus: a focus on toxic hepatitis,” Rheumatology International, vol. 31, no. 1, pp. 79–84, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Takahashi, K. Abe, J. Yokokawa et al., “Clinical features of liver dysfunction in collagen diseases,” Hepatology Research, vol. 40, no. 11, pp. 1092–1097, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Piga, A. Vacca, G. Porru, A. Cauli, and A. Mathieu, “Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis,” Clinical and Experimental Rheumatology, vol. 28, no. 4, pp. 504–510, 2010. View at Google Scholar · View at Scopus
  46. L. A. González, M. Orrego, L. A. Ramírez, and G. Vásquez, “Primary biliary cirrhosis/autoimmune hepatitis overlap syndrome developing in a patient with systemic lupus erythematosus: a case report and review of the literature,” Lupus, vol. 20, no. 1, pp. 108–111, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Takahashi, K. Abe, R. Saito et al., “Liver dysfunction in patients with systemic lupus erythematosus,” Internal Medicine, vol. 52, no. 13, pp. 1461–1465, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. M. El-Shabrawi and M. I. Farrag, “Hepatic manifestations in juvenile systemic lupus erythematosus,” Recent Patents on Inflammation & Allergy Drug Discovery, vol. 8, no. 1, pp. 36–40, 2014. View at Publisher · View at Google Scholar
  49. F. Bessone, N. Poles, and M. G. Roma, “Challenge of liver disease in systemic lupus erythematosus: clues for diagnosis and hints for pathogenesis,” World Journal of Hepatology, vol. 6, no. 6, pp. 394–409, 2014. View at Publisher · View at Google Scholar
  50. M. Piga, A. Vacca, G. Porru, P. Garau, A. Cauli, and A. Mathieu, “Two different clinical subsets of lupus hepatitis exist. Mimicking primary autoimmune liver diseases or part of their spectrum?” Lupus, vol. 20, no. 13, pp. 1450–1451, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Takahashi, T. Rai, M. Onizawa et al., “Autoimmune hepatitis complicated by late-onset systemic lupus erythematosus,” Hepatology Research, vol. 37, no. 9, pp. 771–774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Matsumoto, T. Yoshimine, K. Shimouchi et al., “The liver in systemic lupus erythematosus: pathologic analysis of 52 cases and review of Japanese autopsy registry data,” Human Pathology, vol. 23, no. 10, pp. 1151–1158, 1992. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Ippolito and M. Petri, “An update on mortality in systemic lupus erythematosus,” Clinical and Experimental Rheumatology, vol. 26, no. 5, supplement 51, pp. S72–S79, 2008. View at Google Scholar · View at Scopus
  54. A. Lleo, L. Maroni, S. Glaser, G. Alpini, and M. Marzioni, “Role of cholangiocytes in primary biliary cirrhosis,” Seminars in Liver Disease, vol. 34, no. 3, pp. 273–284, 2014. View at Publisher · View at Google Scholar
  55. B. D. Juran and K. N. Lazaridis, “Environmental factors in primary biliary cirrhosis,” Seminars in Liver Disease, vol. 34, no. 3, pp. 265–272, 2014. View at Publisher · View at Google Scholar
  56. M. E. Gershwin and I. R. Mackay, “The causes of primary biliary cirrhosis: convenient and inconvenient truths,” Hepatology, vol. 47, no. 2, pp. 737–745, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Matsumoto, S. Kobayashi, H. Shimizu et al., “The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver,” Liver, vol. 20, no. 5, pp. 366–373, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. T. H. Karlsen, M. Vesterhus, and K. M. Boberg, “Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis,” Alimentary Pharmacology and Therapeutics, vol. 39, no. 3, pp. 282–301, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. P. K. Nijhawan, T. M. Therneau, E. R. Dickson, J. Boynton, and K. D. Lindor, “Incidence of cancer in primary biliary cirrhosis: the Mayo experience,” Hepatology, vol. 29, no. 5, pp. 1396–1398, 1999. View at Publisher · View at Google Scholar · View at Scopus
  60. A. M. Wolke, F. Schaffner, B. Kapelman, and H. S. Sacks, “Malignancy in primary biliary cirrhosis: high incidence of breast cancer in affected women,” American Journal of Medicine, vol. 76, no. 6, pp. 1075–1078, 1984. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Floreani, I. Franceschet, N. Cazzagon et al., “Extrahepatic autoimmune conditions associated with primary biliary cirrhosis,” Clinical Reviews in Allergy & Immunology, 2014. View at Publisher · View at Google Scholar · View at Scopus
  62. C. Efe, E. Ozaslan, N. Nasiroglu, H. Tunca, T. Purnak, and E. Altiparmak, “The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases: report of three cases and review of the literature,” Digestive Diseases and Sciences, vol. 55, no. 8, pp. 2417–2421, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Rust and U. H. Beuers, “Overlap syndromes among autoimmune liver diseases,” World Journal of Gastroenterology, vol. 14, no. 21, pp. 3368–3373, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Efe, E. Ozaslan, A. Heurgué-Berlot et al., “Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis,” European Journal of Gastroenterology and Hepatology, vol. 26, no. 5, pp. 532–537, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. K. S. Culp, C. R. Fleming, J. Duffy, W. P. Baldus, and E. R. Dickson, “Autoimmune associations in primary biliary cirrhosis,” Mayo Clinic Proceedings, vol. 57, no. 6, pp. 365–370, 1982. View at Google Scholar · View at Scopus
  66. C. Rigamonti, L. M. Shand, M. Feudjo et al., “Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis,” Gut, vol. 55, no. 3, pp. 388–394, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. B. Marasini, M. Gagetta, V. Rossi, and P. Ferrari, “Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients,” Annals of the Rheumatic Diseases, vol. 60, no. 11, pp. 1046–1049, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. F. E. Watt, O. F. W. James, and D. E. J. Jones, “Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study,” Quarterly Journal of Medicine, vol. 97, no. 7, pp. 397–406, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. E. Iwasawa, H. Miyakawa, K. Kikuchi, A. Nimi, M. Hara, and N. Kamatani, “Detection and significance of anti-mitochondrial antibody in various collagen diseases,” Kanzo, vol. 48, no. 5, pp. 210–218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. V. F. Picceli, T. L. Skare, R. Nisihara, L. Kotze, I. Messias-Reason, and S. R. R. Utiyama, “Spectrum of autoantibodies for gastrointestinal autoimmune diseases in systemic lupus erythematosus patients,” Lupus, vol. 22, no. 11, pp. 1150–1155, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. L. C. Kottyan, E. E. Zoller, J. Bene, X. Lu, and J. A. Kelly, “The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmunedisorders variably share,” Human Molecular Genetics, vol. 24, no. 2, pp. 582–596, 2015. View at Publisher · View at Google Scholar
  72. X. Liu, P. Invernizzi, Y. Lu et al., “Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis,” Nature Genetics, vol. 42, no. 8, pp. 658–660, 2010. View at Publisher · View at Google Scholar
  73. G. M. Hirschfield, R. W. Chapman, T. H. Karlsen, F. Lammert, K. N. Lazaridis, and A. L. Mason, “The genetics of complex cholestatic disorders,” Gastroenterology, vol. 144, no. 7, pp. 1357–1374, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. B. Kaleta, “Role of osteopontin in systemic lupus erythematosus,” Archivum Immunologiae et Therapiae Experimentalis, vol. 62, no. 6, pp. 475–482, 2014. View at Publisher · View at Google Scholar
  75. M. Quaglia, A. Chiocchetti, T. Cena et al., “Osteopontin circulating levels correlate with renal involvement in systemic lupus erythematosus and are lower in ACE inhibitor-treated patients,” Clinical Rheumatology, vol. 33, no. 9, pp. 1263–1271, 2014. View at Publisher · View at Google Scholar · View at Scopus
  76. K. Harada, S. Ozaki, Y. Sudo, K. Tsuneyama, H. Ohta, and Y. Nakanuma, “Osteopontin is involved in the formation of epithelioid granuloma and bile duct injury in primary biliary cirrhosis,” Pathology International, vol. 53, no. 1, pp. 8–17, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. K. Kikuchi, A. Tanaka, H. Miyakawa et al., “Eta-1/osteopontin genetic polymorphism and primary biliary cirrhosis,” Hepatology Research, vol. 26, no. 2, pp. 87–90, 2003. View at Publisher · View at Google Scholar · View at Scopus
  78. M. E. J. Deen, G. Porta, F. J. Fiorot, L. M. A. Campos, A. M. E. Sallum, and C. A. A. da Silva, “Autoimmune hepatitis and juvenile systemic lupus erythematosus,” Lupus, vol. 18, no. 8, pp. 747–751, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Teufel, A. Weinmann, G. J. Kahaly et al., “Concurrent autoimmune diseases in patients with autoimmune hepatitis,” Journal of Clinical Gastroenterology, vol. 44, no. 3, pp. 208–213, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. A. J. Czaja, S. A. Morshed, S. Parveen, and M. Nishioka, “Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis,” Hepatology, vol. 26, no. 3, pp. 567–572, 1997. View at Google Scholar · View at Scopus
  81. F. O. Önder, Ö. T. Yürekli, E. Öztaş et al., “Features of systemic lupus erythematosus in patients with autoimmune hepatitis,” Rheumatology International, vol. 33, no. 6, pp. 1581–1585, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. J. M. Koshy and M. John, “Autoimmune hepatitis-SLE overlap syndrome,” Journal of Association of Physicians of India, vol. 60, no. 9, pp. 59–60, 2012. View at Google Scholar · View at Scopus
  83. J. J. Alberti-Flor, L. Jeffers, and E. R. Schiff, “Primary sclerosing cholangitis occurring in a patient with systemic lupus erythematosus and diabetes mellitus,” The American Journal of Gastroenterology, vol. 79, no. 11, pp. 889–891, 1984. View at Google Scholar · View at Scopus
  84. P. Lamy, D. Valla, P. Bourgeois, B. Rueff, and J. P. Benhamou, “Primary sclerosing cholangitis and systemic lupus erythematosus,” Gastroenterologie Clinique et Biologique, vol. 12, no. 12, pp. 962–964, 1988. View at Google Scholar · View at Scopus
  85. A. Audan, S. Bruley Des Varannes, T. Georgelin et al., “Primary sclerosing cholangitis and systemic lupus erythematosus,” Gastroenterologie Clinique et Biologique, vol. 19, no. 1, pp. 123–126, 1995. View at Google Scholar · View at Scopus
  86. H. H. Lutz, C. Trautwein, and J. J. W. Tischendorf, “Primary sclerosing cholangitis: diagnosis and treatment,” Deutsches Arzteblatt International, vol. 110, no. 51-52, pp. 867–874, 2013. View at Publisher · View at Google Scholar · View at Scopus